News
Personalised Immunotherapy Therapies Inching Closer- Study
In an effort to advance personalised cancer treatment, researchers have shown that biomarkers alone cannot predict which patients will benefit most from immunotherapy.
Clinicians should comprehend how immune cells and tumours are functioning within a patient rather than relying solely...
Drug Research
EMA Develops A Quality Control Group To Aid Drug Development
To support innovative approaches for the development, manufacture, and quality control (QC) of medicines, along with new technologies, digitalization, novel materials, and novel devices for patients in the European Union, the European Medicines Agency (EMA) formed the Quality Innovation...
Drug Research
RVAC Medicines and A*STAR to Build Capabilities for mRNA Production in Singapore
RVAC Medicines Pte. Ltd. (RVAC), a messenger RNA (mRNA) technology platform company incubated by CBC Group, a healthcare-dedicated asset management firm headquartered in Singapore, and the Agency for Science, Technology and Research (A*STAR) announced the signing of a master research collaboration agreement...
News
CPhI & P-MEC India expo to encourage cost-effective solutions in India’s march towards a Rs 10.5 lakh crore Pharma Market by 2030
Continuing the winning streak of CPhI & P-MEC India, Informa Markets, the leading international B2B events group is once again back with its 15th edition in an evolved hybrid format to be held from 29th November to 1st December...
Drug Research
Merck Invests € 290 Million in U.S. Drug Safety Testing Capacity
Merck, a leading science and technology company, invests more than € 290 million in its biosafety testing capacity at Rockville, Maryland, USA. This will significantly increase the company’s ability to conduct biosafety testing and analytical development services. Biosafety testing...
Drug Research
Quadripartite launches a new platform to tackle antimicrobial resistance threat to human and animal health and ecosystems
The Antimicrobial Resistance Multi-Stakeholder Partnership Platform was launched to ensure the growing threats and impacts of antimicrobial resistance are addressed globally.
The Food and Agriculture Organization of the United Nations (FAO), the UN Environment Programme (UNEP), the World Health Organization...
News
Novavax Nuvaxovid COVID-19 Vaccine Receives Expanded Authorization in Canada as a Booster in Adults
Novavax, Inc., a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, announced that Health Canada has granted expanded authorization for Nuvaxovid™ (COVID-19 Vaccine (Recombinant protein, Adjuvanted)) (NVX-CoV2373) for active immunization to prevent coronavirus disease...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.